drugset / Trial / NCT07818564
Pilot Study on the Effects of Psilocybin on Belief Updating and Insight Formation
RandomizedParallel-groupTriple-blindBasic science
Summary
The primary aim of this phase I mechanistic pilot study is to evaluate the effects of psilocybin on aspects of cognition in healthy adult volunteers. Up to 24 participants will receive a single dose of either psilocybin or inert placebo, and they will be asked to complete several computer-based behavioral tasks measuring features of learning, belief updating, and abstraction. Participants will also complete measures of subjective experience and expectancy, as well as semi-structured interviews at follow up, to assess whether experience correlates with behavior. This is a Voluntary Submission.
Timeline
- Start
- 2026-11
- Primary completion
- 2027-11
- Completion
- 2027-11
Publications
- Background Lehnert L, Littman ML, Frank MJ. Reward-predictive representations generalize across tasks in reinforcement learning. PLoS Comput Biol. 2020 Oct 15;16(10):e1008317. doi: 10.1371/journal.pcbi.1008317. eCollection 2020 Oct.
- Background Nassar MR, Wilson RC, Heasly B, Gold JI. An approximately Bayesian delta-rule model explains the dynamics of belief updating in a changing environment. J Neurosci. 2010 Sep 15;30(37):12366-78. doi: 10.1523/JNEUROSCI.0822-10.2010.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Psilocybin | Other / unclassified | 25 mg | Oral |
Indications
No indication recorded.